Purdue Pharma

About Purdue Pharma

Purdue Pharma L.P. develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and we are currently led by a physician. Beyond our efforts to provide quality medications, Purdue is committed to supportingĀ national, regional and local collaborations to drive innovations in patient care. Privately held, Purdue is pursuing a pipeline of new medications and technologies through internal research & development and strategic industry partnerships.

Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Stamford, CT, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Coventry, RI, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Wilson, NC, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Stamford, CT, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Wilson, NC, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.
Purdue Pharma Wilson, NC, USA
Jul 29, 2019
Purdue Pharma and its subsidiaries develop and provide prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis. Purdue’s subsidiaries include  Adlon Therapeutics L.P.,  focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders;  Avrio  Health L.P. , a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions;  Imbrium Therapeutics L.P. , established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and  Greenfield  Bioventures  L.P. , an investment vehicle focused on value-inflection in early stages of clinical development.